GlassScriptPhysician profile
Suzanne Fox Alfano
NPI 1184967747
$1,494.42
in general payments reported to CMS, 2019-2025
21 companies · $450 in 2025
The $450 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $124 · 2021: $91.31 · 2022: $36.15 · 2023: $166 · 2024: $358 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $974.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $257.84 | 2019-2025 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $199.65 | 2023-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Corium, LLC | $125.98 | 2024-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $125.65 | 2019-2024 | |
| Seqirus USA INC | $112.10 | 2024-2025 | Flucelvax |
| Kaleo, INC. | $81.77 | 2019-2023 | Auvi-Q |
| Sanofi Pasteur INC. | $71.56 | 2023-2025 | |
| Glaxosmithkline, LLC. | $71.09 | 2019-2025 | Penmenvy, Bexsero, Pediarix |
| Neos Therapeutics, LP | $64.35 | 2024-2025 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Vertical Pharmaceuticals, LLC | $54.78 | 2019-2020 | |
| Genentech USA, INC. | $47.53 | 2019-2020 | |
| Cranial Technologies, INC | $43.76 | 2019-2020 | |
| Alk-Abello, INC | $41.72 | 2025 | Neffy |
| Welch Allyn | $41.04 | 2021 | |
| Collegium Pharmaceutical, INC. | $39.80 | 2025 | Jornay Pm |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $36.90 | 2019 | |
| Verrica Pharmaceuticals INC. | $19.76 | 2024 | Ycanth |
| Sobi, INC | $19.66 | 2021 | |
| Adlon Therapeutics L.P. | $14.04 | 2020 | |
| Mylan Pharmaceuticals INC. | $13.67 | 2019 | |
| Shire North American Group INC | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Alfano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.